TYRO3 and cancer: Having identified cancer cell lines with Tyro3 expression, we selected SCC-25 head and neck carcinoma cells for further study as these cells showed a consistent response to ligand stimulation (Supplementary Figures S1 and S2) and with less potential influence of the other TAM receptors.